Achilles therapeutics appoints bernhard ehmer to board of directors

London, may 04, 2022 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announced the appointment of bernhard ehmer, md, to the board as a non-executive director. bernhard joins achilles with a strong track record in international r&d, regulatory and commercial activities.
ACHL Ratings Summary
ACHL Quant Ranking